ABEO READ THE FULL ABEO RESEARCH REPORT Business Update First Patient Treated with Zevaskyn® Pushed to 4Q25 The first patient treated with Zevaskyn was pushed back to the fourth quarter of 2025 ...
Trisalus Life Sciences, Inc. (($TLSI)) has held its Q3 earnings call. Read on for the main highlights of the call. Trisalus Life Sciences, Inc.
Q3 2025 Earnings Call Transcript November 13, 2025 TriSalus Life Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.96 EPS, expectations were $-0.17. Operator: Good afternoon, and ...
The Centers for Medicare & Medicaid Services (“CMS”) recently finalized a Medicare payment rule with significant implications for life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback